14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 NCNA stock ended at $4.00. This is 0.88% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.40% from a day low at $3.89 to a day high of $4.18.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical NuCana plc prices

Date Open High Low Close Volume
May 03, 2024 $3.91 $4.18 $3.89 $4.00 28 576
May 02, 2024 $4.04 $4.04 $3.92 $3.97 8 398
May 01, 2024 $3.94 $4.10 $3.83 $3.98 6 268
Apr 30, 2024 $4.00 $4.01 $3.84 $3.96 9 285
Apr 29, 2024 $4.14 $4.28 $3.98 $4.00 13 796
Apr 26, 2024 $3.89 $4.00 $3.85 $4.00 6 746
Apr 25, 2024 $4.00 $4.00 $3.54 $3.81 16 144
Apr 24, 2024 $4.01 $4.09 $3.75 $3.84 12 007
Apr 23, 2024 $4.01 $4.13 $3.82 $4.00 37 241
Apr 22, 2024 $3.85 $4.20 $3.85 $3.99 50 821
Apr 19, 2024 $3.70 $3.82 $3.40 $3.78 32 480
Apr 18, 2024 $4.08 $4.18 $3.61 $3.79 87 196
Apr 17, 2024 $4.06 $4.40 $3.84 $3.97 108 050
Apr 16, 2024 $4.67 $5.14 $3.69 $3.90 121 258
Apr 15, 2024 $0.217 $0.227 $0.178 $0.178 795 819
Apr 12, 2024 $0.237 $0.239 $0.215 $0.224 248 662
Apr 11, 2024 $0.237 $0.240 $0.230 $0.237 119 670
Apr 10, 2024 $0.237 $0.237 $0.225 $0.237 225 607
Apr 09, 2024 $0.244 $0.244 $0.226 $0.237 247 061
Apr 08, 2024 $0.242 $0.242 $0.227 $0.236 313 733
Apr 05, 2024 $0.244 $0.244 $0.226 $0.233 252 696
Apr 04, 2024 $0.262 $0.262 $0.225 $0.239 174 242
Apr 03, 2024 $0.236 $0.262 $0.224 $0.262 432 975
Apr 02, 2024 $0.245 $0.245 $0.224 $0.230 619 512
Apr 01, 2024 $0.248 $0.251 $0.227 $0.237 503 429
Click to get the best stock tips daily for free!

About NuCana plc

NuCana plc NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary trac... NCNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT